Private Advisor Group’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $198K | Buy |
5,885
+700
| +14% | +$23.6K | ﹤0.01% | 2237 |
|
|
2025
Q1 | $165K | Buy |
5,185
+647
| +14% | +$20.6K | ﹤0.01% | 2132 |
|
|
2024
Q4 | $176K | Buy |
4,538
+144
| +3% | +$5.59K | ﹤0.01% | 2111 |
|
|
2024
Q3 | $198K | Buy |
4,394
+55
| +1% | +$2.48K | ﹤0.01% | 2228 |
|
|
2024
Q2 | $181K | Sell |
4,339
-287
| -6% | -$12K | ﹤0.01% | 2172 |
|
|
2024
Q1 | $211K | Sell |
4,626
-824
| -15% | -$37.5K | ﹤0.01% | 2082 |
|
|
2023
Q4 | $252K | Sell |
5,450
-139,030
| -96% | -$6.43M | ﹤0.01% | 1898 |
|
|
2023
Q3 | $5.88M | Sell |
144,480
-99,723
| -41% | -$4.06M | 0.05% | 343 |
|
|
2023
Q2 | $11.8M | Sell |
244,203
-9,571
| -4% | -$464K | 0.1% | 194 |
|
|
2023
Q1 | $12.5M | Sell |
253,774
-14,540
| -5% | -$717K | 0.12% | 176 |
|
|
2022
Q4 | $188K | Sell |
268,314
-33,688
| -11% | -$23.7K | 0.01% | 895 |
|
|
2022
Q3 | $15.2M | Buy |
302,002
+7,284
| +2% | +$366K | 0.17% | 123 |
|
|
2022
Q2 | $14.4M | Buy |
294,718
+86,271
| +41% | +$4.22M | 0.13% | 164 |
|
|
2022
Q1 | $12.5M | Buy |
208,447
+38,250
| +22% | +$2.3M | 0.1% | 203 |
|
|
2021
Q4 | $13.5M | Buy |
170,197
+37,172
| +28% | +$2.95M | 0.1% | 200 |
|
|
2021
Q3 | $11.8M | Buy |
133,025
+95,881
| +258% | +$8.49M | 0.07% | 263 |
|
|
2021
Q2 | $3.7M | Buy |
+37,144
| New | +$3.7M | 0.03% | 509 |
|